menu
    • menu

    Company profile for InflaRx

    NEW Drugs in Dev: 6
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena an...
    InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InflaRxGermany Flag
    Country
    Country
    Germany
    Address
    Address
    InflaRx N.V. Winzerlaer Str. 2 07745 Jena
    Telephone
    Telephone
    +49 (0)3641 508 180
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.inflarx.de/Home.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arab Health

    Arab Health

    Not Confirmed

    envelop Contact Supplier

    Arab Health

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inflarx Announces Participation In February Investor Conferences
    Inflarx Announces Participation In February Investor Conferences

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3228469/0/en/InflaRx-Announces-Participation-in-February-Investor-Conferences.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    InflaRx Cuts Costs, Trims Staff By 30%, Shifts Focus
    InflaRx Cuts Costs, Trims Staff By 30%, Shifts Focus

    09 Jan 2026

    // BIOSPACE

    https://www.biospace.com/business/inflarx-stanches-spending-with-30-staff-reduction-priority-pivot

    BIOSPACE
    09 Jan 2026
    Share Share
    InflaRx Emphasizes Capital-Efficient Strategy For Izicopan
    InflaRx Emphasizes Capital-Efficient Strategy For Izicopan

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215352/0/en/InflaRx-Announces-Strategy-Focused-on-Capital-Efficient-Execution-with-Izicopan-and-Near-Term-Value-Creation.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    InflaRx Charts Layoffs, Cost Cuts To Lift Lead Asset's Prospects
    InflaRx Charts Layoffs, Cost Cuts To Lift Lead Asset's Prospects

    08 Jan 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/inflarx-prune-headcount-30-curb-covid-drug-spending-bid-advance-new-favorite-asset-izicopan

    FIERCE PHARMA
    08 Jan 2026
    Share Share
    Inflarx Updates Ph3 Data For Vilobelimab In Pyoderma Gangrenosum
    Inflarx Updates Ph3 Data For Vilobelimab In Pyoderma Gangrenosum

    30 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/30/3211327/0/en/InflaRx-Provides-Update-on-Phase-3-Data-Analyses-for-Vilobelimab-in-Pyoderma-Gangrenosum.html

    GLOBENEWSWIRE
    30 Dec 2025
    Share Share
    InflaRx Announces Nonproprietary Name of “izicopan” for Inf904
    InflaRx Announces Nonproprietary Name of “izicopan” for Inf904

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203812/0/en/InflaRx-Announces-International-Nonproprietary-Name-of-Izicopan-for-INF904.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search